Detection of autoantibodies against survivin in sera from cancer dogs

Journal of Veterinary Medical Science

Volumn 72, Issue 7, 2010, Pages 917-920

  Tango, Yumiko ^a   Kano, Rui ^a   Maruyama, Haruhiko ^a   Asano, Kazushi ^a   Tanaka, Shigeo ^a   Hasegawa, Astuhiko ^b   Kamata, Hiroshi ^a  

^a NIHON UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Autoantibodies; Cancer; Canine; ELISA; Survivin

Indexed keywords

AUTOANTIBODY; MICROTUBULE ASSOCIATED PROTEIN; PRIMER DNA;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; DOG; DOG DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; GENE AMPLIFICATION; HUMAN; IMMUNOLOGY; METHODOLOGY; NEOPLASM; PROCEDURES; VETERINARY;

ANIMALS; AUTOANTIBODIES; DNA PRIMERS; DOG DISEASES; DOGS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; GENE AMPLIFICATION; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASMS;

CANIS FAMILIARIS;

EID: 77955235711     PISSN: 09167250     EISSN: 13477439     Source Type: Journal    
DOI: 10.1292/jvms.09-0476     Document Type: Article

References (13)

1. Adida, C., Crotty, P.L., McGrath, J., Berrebi, D., Diebold, J. and Altieri, D.C. 1998. Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation. Am. J. Pathol. 152: 43-49.
2. Altznauer, F., Martinelli, S., Yousefi, S., Thürig, C., Schmid, I., Conway, E. M., Schöni, M. H., Vogt, P., Mueller, C., Fey, M. F., Zangemeister-Wittke, U. and Simon, H. U. 2004. Inflammation-associated cell cycle-independent block of apoptosis by survivin in terminally differentiated neutrophils. J. Exp. Med. 17: 1343-1354.
3. Ambrosini, G., Adida, C. and Altieri, D.C. 1997. A novel antiapoptosis gene, survivin, expressed in cancer and lymphoma. Nat. Med. 3: 917-921.
4. Lo Muzio, L., Staibano, S., Pannone, G., Mignogna, M.D., Mariggiò, A., Salvatore, G., Chieffi, P., Tramontano, D., De Rosa, G. and Altieri, D.C. 2001. Expression of the apoptosis inhibitor survivin in aggressive squamous cell carcinoma. Exp. Mol. Pathol. 70: 249-254.
5. Ma, Y.P., Zou, P., Xiao, J. and Huang, S.A. 2003. Expression of survivin in cord blood CD34(+) stem/progenitor cells and its significance. Zhonghua Xue Ye Xue Za Zhi 24: 238-240.
6. Megliorino, R., Shi, F.-D., Peng, X.-X., Wang, X., Chan, E. K. L., Tan, E. M. and Zhang, J-Y. 2005. Autoimmune response to anti-apoptotic survivin and its association with antibodies to p53 and c-myc in cancer detection. Cancer. Detect. Prev. 29: 241-248.
7. Rankin, W.V., Henry, C.J., Turnquist, S.E., Turk, J.R., Beissenherz, M.E., Tyler, J.W. and Green, J.A. 2008. Comparison of distribution of survivin among tissues from urinary bladders of dogs with cystitis, transitional cell carcinoma, or histologically normal urinary bladders. Am. J. Vet. Res. 69: 1073-1078.
8. Rebhun, R.B., Lana, S.E., Ehrhart, E.J., Charles, J.B. and Thamm, D.H. 2008. Comparative analysis of survivin expression in untreated and relapsed canine lymphoma. J. Vet. Intern. Med. 22: 989-995.
9. Scase, T.J., Edwards, D., Miller, J., Henley, W., Smith, K., Blunden, A. and Murphy, S. 2006. Canine mast cell tumors: correlation of apoptosis and proliferation markers with prognosis. J. Vet. Intern. Med. 20: 151-158.
10. Yagihashi, A., Asanuma, K., Kobayashi, D., Tsuji, N., Shijubo, Y., Abe, S., Hirohashi, Y., Torigoe, T., Sato, N. and Watanabe, N. 2005. Detection of autoantibodies to livin and survivin in sera from lung cancer patients. Lung. Cancer 48: 217-221.
11. Yagihashi, A., Ohmura, T., Asanuma, K., Kobayashi, D., Tsuji, N., Torigoe, T., Sato, N., Hirata, K. and Watanabe, N. 2005. Detaction of autoantibodies to livin and survivin in sera from patients with breast cancer. Clin. Chimica. Acta 362: 125-130.
12. Sohn, D.M., Kim, S.Y., Baek, M.J., Lim, C.W., Lee, M.H., Cho, M.S. and Kim, T.Y. 2006. Expression of survivin and clinical correlation in patients with breast cancer. Biomed. Pharmacother. 60: 289-292.
13. Xiang, X.J. and He, Y.J. 2006. Clinical significance of survivin and caspase-3 expression in diffuse large B-cell lymphoma. Zhonghua Zhong Liu Za Zhi 28: 298-301.